| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |